Expanded collaboration delivers secure and scalable transaction processing for specialty and infusion pharmacies managing complex therapies BOWIE, Md., Feb. 12,Expanded collaboration delivers secure and scalable transaction processing for specialty and infusion pharmacies managing complex therapies BOWIE, Md., Feb. 12,

Inovalon Named Global Leaders Champion for Scaling ScriptMed® on Oracle AI Database to Power Pharmacy Operations

2026/02/12 21:30
3 min read

Expanded collaboration delivers secure and scalable transaction processing for specialty and infusion pharmacies managing complex therapies

BOWIE, Md., Feb. 12, 2026 /PRNewswire/ — Inovalon, a leading provider of data and solutions empowering data-driven healthcare, announced the continued expansion of its collaboration with Oracle to standardize its ScriptMed® specialty and infusion pharmacy management software on Oracle Autonomous AI Database on Oracle Cloud Infrastructure (OCI). In addition, Oracle has named Inovalon a Global Leaders Champion in recognition of its leadership and innovation in using Oracle Autonomous AI Database to scale ScriptMed for transaction processing.

“In selecting Oracle Global Leaders Champions, Oracle identifies companies who are leaders in their domain and demonstrate success implementing Oracle data management solutions,” said Çetin Özbütün, executive vice president, Autonomous AI Database Technologies, Oracle. “A company like Inovalon, with a demonstrated ability to operate at significant scale while continuing to innovate, is a natural choice for our 2025 Global Leaders Champion recognition.”

The specialty pharmacy and infusion sectors are growing rapidly, driven by a rich pipeline of breakthrough complex therapies that also tighten regulatory and data requirements. Traditional pharmacies relying on costly on‑premises infrastructure and manual database management are struggling to keep pace with rising transaction volumes and scalability needs.

The expanded collaboration is designed to equip pharmacies with a robust, flexible, and scalable technology solution that supports rapid growth and rising transaction volumes. With ScriptMed on Oracle Autonomous AI Database, pharmacies can shift from managing infrastructure to growing their business, confidently launching new therapies, expanding to new locations, and handling higher patient volumes.

“Our expanded engagement with Oracle is more than infrastructure. It’s a strategic foundation for pharmacies to thrive in this era of growth, reflecting how pharmacy operations are evolving to remove barriers in favor of prioritizing patient-centric care amid rising therapy complexity and volume,” said Ernie Shopes, President of Inovalon’s Pharmacy Business Unit. “As specialty and infusion pharmacies grow, the technology supporting them must be robust, flexible, and ready to scale without delay.”

ScriptMed is Inovalon’s comprehensive, data-enabled, end-to-end solution that helps specialty and infusion pharmacy operations reduce time-to-fill, lower costs, enhance patient experience, and improve outcomes. The software supports prescription intake, dispensing workflows, fulfillment, inventory management, clinical management, revenue cycle management, and general day-to-day transaction processing within secure, compliant environments.

Learn more about Inovalon’s ScriptMed pharmacy management software.

About Inovalon

Inovalon is a leading provider of data and solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by over 50,000 active, licensed customers, and are informed by the primary source data of more than 97 billion medical events across 1.1 million physicians, 717,000 clinical settings, and 454 million unique lives. For more information, visit www.inovalon.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inovalon-named-global-leaders-champion-for-scaling-scriptmed-on-oracle-ai-database-to-power-pharmacy-operations-302685762.html

SOURCE Inovalon

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

UAE Launches First Regulated Stablecoin as ADI Trends Higher

UAE Launches First Regulated Stablecoin as ADI Trends Higher

The United Arab Emirates has officially launched its first regulated stablecoin, marking another step in the region’s expanding digital asset infrastructure. According
Share
Ethnews2026/02/13 00:23
The Ultimate Guide to Professional Dog Grooming: Choosing the Right Tools for a Salon-Finish at Home

The Ultimate Guide to Professional Dog Grooming: Choosing the Right Tools for a Salon-Finish at Home

Every dog owner knows that grooming is more than just a beauty routine—it is a vital part of your pet’s health and happiness. Whether you are a professional stylist
Share
Techbullion2026/02/13 00:17
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Share
BitcoinEthereumNews2025/09/18 01:44